ArticleBritish journal of pharmacology2017

Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis.

Brian C Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.